Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Find Strong Buy Stocks for the Coronavirus Market Rally with this Screener

Published 06/02/2020, 07:27 AM
Updated 07/09/2023, 06:31 AM

The market rally is gaining momentum again, as economies around the world and in the U.S. roll back coronavirus lockdown measures. Investors and Wall Street also seem likely to remain in ‘don’t fight the Fed' mode, and the recent protests and unrest have not seemed to deter investors so far.

The stock market has clearly been ahead of the actual economy. Luckily, there are plenty of signs that the economic recovery might be quick (also read: Three Reasons Why the Coronavirus Economic Recovery will be Quick).

With this in mind, investors might want to add some more stocks to their portfolios. So today we utilized our Filtered Zacks Rank 5 Screener to help find strong stocks.

Zacks Rank #1 (Strong Buy) stocks outperform the market in both good and bad times. However, there are over 200 stocks that earn a Zacks Rank #1 at any given time. Therefore, it is extremely helpful to understand how to apply filters to the Zacks Rank in order to narrow the list down to a more manageable and tradable set of stocks.

Today, we are going to show investors how to add two relatively simple filters to our Zacks Rank #1 criteria in order to narrow down the number of stocks and try to increase performance as well…

Parameters

Clearly, there are only three items on this screen. But together, these three filters can result in some impressive returns.

• Zacks Rank equal to 1

Starting with a Zacks Rank #1 is often a strong jumping off point because it boasts an average annual return of roughly 24.5% per year since 1988.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

• % Change (Q1) Est. over 4 Weeks greater than 0

Positive current quarter estimate revisions over the last four weeks.

The Zacks Rank looks at earnings estimate revisions for the current year (F1) and the next year (F2). The additional component factors in current quarter (Q1) estimate revisions. The idea is pretty simple.

A company that has experienced downward revisions for the current quarter could soon see longer-term negative revisions. Meanwhile, if a company has earned positive earnings revisions for its current quarter, it might signal that more upward revisions could be coming down the road, which would make it an attractive buy.

• % Broker Rating Change over 4 Week equal to Top # 5

Top 5 stocks with the best average broker rating changes over the last four weeks.

In this screen, we are searching for positive broker rating changes or upgrades over the last four weeks. On top of that, we want to cut down on the number of stocks that come through. So, we configured the screen to select the top 5 stocks with the best broker rating upgrade.

Investors should note that broker ratings typically lean toward the upside. Therefore, our screen makes sure that the brokers are getting more bullish, or at the least not getting less bullish (or even bearish) on the stock.

It is worth noting that the actual broker ratings do not matter as much as the upgrade itself, because stocks with broker rating upgrades have been proven to outperform their counterparts that do not earn positive broker rating changes or downgrades.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This strategy comes loaded with the Research Wizard and is called bt_sow_filtered zacks rank5. It can be found in the SoW (Screen of the Week) folder.

Here are 3 of the 5 stocks that qualified for the Filtered Zacks Rank 5 strategy today…

BG Foods, Inc. (BGS)

Mersana Therapeutics (NASDAQ:MRSN), Inc. (MRSN)

Co-Diagnostics (NASDAQ:CODX), Inc. (CODX)

See the rest of the stocks on this list and start trading the Filtered Zacks Rank 5 (or any of our other strategies) in your own account. Remember, the key to successful screening is finding screens that have produced profitable results in the past. And that's exactly what you get with the Research Wizard stock picking and backtesting program.

Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it.

Click here to sign up for a free trial to the Research Wizard today.

Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance/

Today's Stocks from Zacks' Best Screens

Now would you like to screen for the latest stocks from Zacks' most successful strategies? From 2017 through Q3 2019, while the market gained +39.6%, we saw results like these: Big Money Zacks +57.5%, Small-Cap Growth +43.1%,Technical Analysis & Fundamental Analysis +96.9%, New Highs +119.0%, and Filtered Zacks Rank 5 +158.9%.

You're invited to screen the latest stocks in seconds by trying Zacks' Research Wizard stock-picking program. Or use the Wizard to create your own market-beating strategies. No credit card needed, no cost or obligation.

Try it for 2 weeks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Mersana Therapeutics, Inc. (MRSN): Free Stock Analysis Report

CoDiagnostics, Inc. (CODX): Free Stock Analysis Report

BG Foods, Inc. (BGS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.